These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 10083624

  • 21. The effect of idarubicin monoclonal antibody treatment of first-set rejection of murine skin allografts.
    Smyth MJ, McKenzie IF, Pietersz GA.
    Transplantation; 1989 Jul; 48(1):77-9. PubMed ID: 2665240
    [Abstract] [Full Text] [Related]

  • 22. Effect of low-molecular-weight heparin on development of cardiac allograft vascular disease following heart transplantation in rats.
    Hisatomi K.
    Transplant Proc; 1998 Dec; 30(8):4337-9. PubMed ID: 9865378
    [No Abstract] [Full Text] [Related]

  • 23. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
    Weetall M, Digan ME, Hugo R, Mathew S, Hopf C, Tart-Risher N, Zhang J, Shi V, Fu F, Hammond-McKibben D, West S, Brack R, Brinkmann V, Bergman R, Neville D, Lake P.
    Transplantation; 2002 May 27; 73(10):1658-66. PubMed ID: 12042656
    [Abstract] [Full Text] [Related]

  • 24. Prolonged survival of mouse cardiac allografts after CD4 or CD8 monoclonal antibody therapy is associated with selective intragraft cytokine protein expression: interleukin (IL)-4 and IL-10 but not IL-2 or interferon-gamma.
    Hancock W, Mottram PL, Purcell LJ, Han WR, Pietersz GA, McKenzie IF.
    Transplant Proc; 1993 Oct 27; 25(5):2937-8. PubMed ID: 8212290
    [No Abstract] [Full Text] [Related]

  • 25. Effect of Tranilast on chronic graft vascular disease and tracheal proliferation in a rat allograft model.
    Teranishi K, Usui A, Maseki T, Watanabe T, Yasuura K, Imaizumi M.
    Transplant Proc; 1999 Nov 27; 31(7):2772-4. PubMed ID: 10578286
    [No Abstract] [Full Text] [Related]

  • 26. Deficiencies of IL-4 or TNF-alpha receptor-1 do not diminish graft arteriosclerosis in cardiac allografts.
    Nagano H, Tilney NL, Stinn JL, Becker G, Hasegawa S, Libby P, Mitchell RN.
    Transplant Proc; 1999 Nov 27; 31(1-2):152. PubMed ID: 10083053
    [No Abstract] [Full Text] [Related]

  • 27. The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis.
    Tuuminen R, Nykänen A, Keränen MA, Krebs R, Alitalo K, Koskinen PK, Lemström KB.
    Transplant Proc; 2006 Dec 27; 38(10):3271-3. PubMed ID: 17175246
    [Abstract] [Full Text] [Related]

  • 28. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies.
    Isobe M, Suzuki J, Yagita H, Okumura K, Yamazaki S, Nagai R, Yazaki Y, Sekiguchi M.
    J Immunol; 1994 Dec 15; 153(12):5810-8. PubMed ID: 7527450
    [Abstract] [Full Text] [Related]

  • 29. Infiltrating cells in mouse cardiac allografts after anti-CD4 monoclonal antibody treatment.
    Han WR, Mottram PL, Purcell LJ, Plenter RJ, McKenzie IF.
    Transplant Proc; 1995 Jun 15; 27(3):2163. PubMed ID: 7792920
    [No Abstract] [Full Text] [Related]

  • 30. Effects of anti-L3T4 and anti-LYT2 monoclonal antibody therapy on cardiac allograft survival in presensitized recipients.
    Madsen JC, Wood KJ, Morris PJ.
    Transplant Proc; 1989 Feb 15; 21(1 Pt 1):1022. PubMed ID: 2495588
    [No Abstract] [Full Text] [Related]

  • 31. Cytokine expression in cardiac allografts in mice with peripheral tolerance induced by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Suzuki J, Isobe M, Sekiguchi M, Maemura K, Nagai R, Yazaki Y.
    Transplant Proc; 1995 Feb 15; 27(1):370-1. PubMed ID: 7879024
    [No Abstract] [Full Text] [Related]

  • 32. Cyclosporine A: graft survival and cardiotoxicity in murine cardiac allografts.
    Mirisklavos A, Mottram PL, Smith JA, Mason A, Dumble LJ, Clunie GJ, Panagiotopoulos S, Nayler WG.
    Transplant Proc; 1987 Feb 15; 19(1 Pt 2):1259-61. PubMed ID: 3274313
    [No Abstract] [Full Text] [Related]

  • 33. Anergic cells generated in vitro suppress rejection response to islet allografts.
    Luo Z, Gotoh M, Grochowiecki T, Tanaka T, Kimura F, Kawashima H, Yagita H, Okumura K, Miyasaka M.
    Transplant Proc; 1999 Feb 15; 31(1-2):623. PubMed ID: 10083265
    [No Abstract] [Full Text] [Related]

  • 34. Prevention of cardiac allograft arteriopathy by antisense Cdc2 kinase oligonucleotide.
    Suzuki J, Izawa A, Morishita R, Kaneda Y, Sawa Y, Okubo Y, Ogihara T, Sekiguchi M, Isobe M.
    Transplant Proc; 1999 Feb 15; 31(1-2):867-8. PubMed ID: 10083378
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of low molecular weight heparin on graft vascular disease in the rat cardiac allograft model.
    Teranishi K, Poston RS, Reitz BA, Robbins RC.
    Transplant Proc; 1999 Feb 15; 31(1-2):103-5. PubMed ID: 10083030
    [No Abstract] [Full Text] [Related]

  • 38. Inhibitory effect of 15-deoxyspergualin on coronary arteriosclerosis in the transplanted heart.
    Hachida M, Zhang X, Lu H, Hoshi H, Koyanagi H.
    Transplant Proc; 1999 Feb 15; 31(1-2):143-6. PubMed ID: 10083050
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.